Publication | Open Access
Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients.
288
Citations
24
References
1996
Year
Nitric OxideImmunologyPathologyOrthopaedic SurgeryInflammatory ArthritisOxidative StressInflammationRheumatoid DisorderReactive Nitrogen SpecieOsteoarthritisInflammatory Rheumatic DiseaseOsteoarthritis PatientsRheumatoid ArthritisRheumatologyAutoimmune DiseaseTissue MacrophagesDisease BiologySynovial MembranePharmacologyInflammatory DiseaseAnti-inflammatorySpontaneous Nitric OxideMedicineNitrosative Stress
We have demonstrated spontaneous nitric oxide (NO) production by primary synovial cultures from rheumatoid (RA) and osteoarthritis patients. Increased NO production followed addition of staphylococcal enterotoxin B. Immunochemical double staining with specific anti-human inducible NO synthase (iNOS) and nonspecific esterase (NSE), or anti-CD68 (markers for tissue macrophages) showed that although many lining layer cells in RA synovium expressed iNOS, most (approximately 90%) were NSE- and CD68-, with only a minor population (approximately 10%) which were iNOS+, CD68+/NSE+. These data demonstrate the capacity for high output of NO by human synovial tissue and show that, although human macrophages can express high levels of iNOS, the majority of cells expressing iNOS are fibroblasts. We also report that synoviocytes, and macrophage cell lines, cultured with the NO donor, S-nitroso-acetyl penicillamine, produced high concentrations of tumor necrosis factor (TNF)-alpha. These results suggest that NO may mediate pathology in RA through the induction of TNF-alpha production.
| Year | Citations | |
|---|---|---|
Page 1
Page 1